ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Process Engineering Co-op at Beam Therapeutics - ApplyBlast

Process Engineering Co-op

Beam Therapeutics

1 month ago

4.1 on Glassdoor

Cambridge, Massachusetts, United States

Onsite

Internship

Intern

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

Beam Therapeutics is seeking a Process Engineering Co-op to join the LNP Development Team for a six-month term from January through June 2027. The role involves supporting the scale-up, optimization, and process development of targeted lipid nanoparticle (tLNP) manufacturing processes. The co-op will collaborate with cross-functional teams to troubleshoot challenges, analyze data, and contribute to the advancement of next-generation LNP formulations.

Responsibilities

Support development and scale-up of targeted lipid nanoparticle manufacturing processes
Conduct formulation studies and execute laboratory experiments to evaluate product quality attributes
Collaborate with cross-functional teams to advance project objectives and troubleshoot manufacturing challenges

Skills

Qualifications

BS in BioengineeringBS in BiochemistryMS in BioengineeringMS in Biochemistry

About Beam Therapeutics

beamtx.com

Headquarters

Cambridge, Massachusetts, United States

Company Size

501-1000 employees

Founded

2017

View Profile

Beam Therapeutics is a clinical-stage biotechnology company based in Cambridge, MA, pioneering precision genetic medicines using its proprietary base editing platform to make precise single‑base DNA changes without creating double‑strand breaks. The company advances both in vivo and ex vivo programs across hematology, rare genetic diseases, and oncology, moving several candidates toward clinical development. Beam combines engineered editors, delivery technologies, and extensive safety profiling to create durable, potentially one‑time treatments and partners with academic and industry collaborators to accelerate translation.